Intestinal T-cell lymphomas: A retrospective analysis of 68 cases in China

Figure 1 Survival curve. A: The Kaplan-Meier cumulative survival curve. The median cumulative survival was 3 mo (3.00 ± 0.48); B: Kaplan-Meier survival curves of the perforated group and the non-perforated group. The cumulative survival of the perforated group (n = 39) was significantly worse than that of the non-perforated group (n = 24) (7.12 ± 2.46 vs 12.00 ± 2.67, P = 0.008); C: Kaplan-Meier survival curves of the cyclophosphamide group and the no cyclophosphamide group. The cumulative survival of the no CHOP group (n = 47) was significantly worse than that of the CHOP group (n = 16) (8.32 ± 2.65 vs 15.97 ± 3.04, P = 0.003). CHOP: Cyclophosphamide.